DNAe Unveils Early Access Program for LiDia‑SEQ™: Hospital Teams Invited to Trial DNAe’s Flagship Tests and Preview DNAe’s Innovative NGS Diagnostic Platform
— New priority program opens up exclusive opportunities for collaborative research on transformative clinical potential ofDNAe's flagship tests and to gain preview of breakthrough LiDia-SEQ™ platform DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, today unveils a new Early Access Program, offering clinical partners an exclusive pre-launch preview of […]